Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 1652-1656, May 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milner, J. A.
Right arrow Articles by Hsu, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milner, J. A.
Right arrow Articles by Hsu, C. Y.

Inhibitory Effects of Selenium on the Growth of L1210 Leukemic Cells1

J. A. Milner and C. Y. Hsu

Department of Food Science, University of Illinois, Urbana, Illinois 61801

Selenium has been shown to inhibit L1210 cells both in vitro and in vivo. The death of L1210 cells in vitro as indicated by trypan blue exclusion was dependent upon the form and concentration of selenium tested. Incubation of L1210 cells in buffer containing selenium at 1 µg/ml for 1 hr prior to inoculation into mice significantly retarded the ability of the cells to propagate in vivo. Sodium selenite injected i.p. increased the longevity of mice inoculated with L1210 cells. Administration of 40 µg selenium as sodium selenite daily for 7 days resulted in a 65% increase in longevity of mice inoculated with 105 L1210 cells. Injections of sodium selenite at doses of 40 µg/day or less for 7 days did not significantly alter growth, liver weight, or red and white blood cell counts. The efficacy of selenium therapy was dependent upon the total number of tumor cells given in the initial inoculum. Selenium administration as sodium selenite was shown to be more effective in increasing the longevity of L1210-inoculated mice than was treatment with sodium selenate, selenocystine, or selenomethionine. Sodium selenite treatment at 20, 30, or 40 µg/day in mice inoculated with 102 cells resulted in 50, 80, and 90% cures, respectively. Supplementation of the drinking water with 3 ppm selenium as sodium selenite increased the longevity of L1210-inoculated mice by approximately 30%. Combined therapy with selenium (30 µg/day) and methotrexate resulted in a significantly longer life span of L1210-treated mice than resulted from either compound administered separately.

1 Supported in part by United States Department of Agriculture Science and Education Administration Grant 5901-410-9-0243-0. Presented in part at the annual meetings of the Federation of the American Societies of Experimental Biology (12) and the Second International Symposium on Selenium in Biology and Medicine, 1980 (13).

Received 8/18/80. Accepted 1/16/81.




This article has been cited by other articles:


Home page
Toxicol SciHome page
N. V. Gopee, V. J. Johnson, and R. P. Sharma
Sodium Selenite-Induced Apoptosis in Murine B-Lymphoma Cells Is Associated with Inhibition of Protein Kinase C-{delta}, Nuclear Factor {kappa}B, and Inhibitor of Apoptosis Protein
Toxicol. Sci., April 1, 2004; 78(2): 204 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Zhou, H. Xiao, T.-K. Li, A. Nur-E-Kamal, and L. F. Liu
DNA Damage-mediated Apoptosis Induced by Selenium Compounds
J. Biol. Chem., August 8, 2003; 278(32): 29532 - 29537.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Reid, A. J. Duffield-Lillico, L. Garland, B. W. Turnbull, L. C. Clark, and J. R. Marshall
Selenium Supplementation and Lung Cancer Incidence: An Update of the Nutritional Prevention of Cancer Trial
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1285 - 1291.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-S. Park, S.-H. Huh, Y. Kim, J. Shim, S.-H. Lee, I.-S. Park, Y.-K. Jung, I. Y. Kim, and E.-J. Choi
Selenite Negatively Regulates Caspase-3 through a Redox Mechanism
J. Biol. Chem., March 17, 2000; 275(12): 8487 - 8491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-S. Park, E. Park, M.-S. Kim, K. Ahn, I. Y. Kim, and E.-J. Choi
Selenite Inhibits the c-Jun N-terminal Kinase/Stress-activated Protein Kinase (JNK/SAPK) through a Thiol Redox Mechanism
J. Biol. Chem., January 28, 2000; 275(4): 2527 - 2531.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
J. H. Lange
Reanalysis of Epidemiological Data for Selenium Anti-Cancer Activity
Toxicology and Industrial Health, July 1, 1991; 7(4): 319 - 325.
[Abstract] [PDF]


Home page
International Journal of ToxicologyHome page
C. Ip
The Chemopreventive Role of Selenium in Carcinogenesis
International Journal of Toxicology, January 1, 1986; 5(1): 7 - 20.
[PDF]


Home page
International Journal of ToxicologyHome page
D. Medina
Mechanisms of Selenium Inhibition of Tumorigenesis
International Journal of Toxicology, January 1, 1986; 5(1): 21 - 27.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.